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ABSTRACT
Fetal bovine serum (FBS) is the most commonly used supplement in studies involving cell-culture
experiments. However, FBS contains large numbers of bovine extracellular vesicles (EVs), which
hamper the analyses of secreted EVs from the cell type of preference and, thus, also the down-
stream analyses. Therefore, a prior elimination of EVs from FBS is crucial. However, the current
methods of EV depletion by ultracentrifugation are cumbersome and the commercial alternatives
expensive. In this study, our aim was to develop a protocol to completely deplete EVs from FBS,
which may have wide applicability in cell-culture applications. We investigated different EV-
depleted FBS prepared by our novel ultrafiltration-based protocol, by conventionally used over-
night ultracentrifugation, or commercially available depleted FBS, and compared themwith regular
FBS. All sera were characterized by nanoparticle tracking analysis, electron microscopy, Western
blotting and RNA quantification. Next, adipose-tissue mesenchymal stem cells (AT-MSCs) and
cancer cells were grown in the media supplemented with the three different EV-depleted FBS
and compared with cells grown in regular FBS media to assess the effects on cell proliferation,
stress, differentiation and EV production. The novel ultrafiltration-based protocol depleted EVs
from FBS clearly more efficiently than ultracentrifugation and commercial methods. Cell prolifera-
tion, stress, differentiation and EV production of AT-MSCs and cancer cell lines were similarly
maintained in all three EV-depleted FBS media up to 96 h. In summary, our ultrafiltration protocol
efficiently depletes EVs, is easy to use andmaintains cell growth and metabolism. Since the method
is also cost-effective and easy to standardize, it could be used in a wide range of cell-culture
applications helping to increase comparability of EV research results between laboratories.
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Introduction
The supplementation of basal culture media with serum is
essential for cell growth, metabolism and stimulation of
proliferation. The most widely used supplements are
bovine sera of adult or newborn animals, or of fetal origin.
FBS contains factors required for cell attachment and
proliferation, and is thus used as a universal growth sup-
plement for most types of human and animal cells [1].
One such factor in FBS is the extracellular vesicles (EVs),
the importance of which has become evident only recently
[2,3]. EVs, secreted by all cells, play a key role in cell-to-
cell communication by shuttling protein, lipids, RNA and
other molecules between cells with diverse functional
consequences in health and various diseases including
cancer [4–7]. For example, therapeutic activities in adi-
pose-derived mesenchymal stem cells (AT-MSCs) are
mediated by EVs along with other paracrine signalling
routes [8,9]. The MSC EVs have a unique capability to
induce regeneration of damaged tissues offering a para-
digm shift towards cell-free therapy [10,11].
However, EV research is currently hampered by the
fact that it relies on cell-culture experiments using FBS,
which contains a large amount of EVs that are mor-
phologically, and largely also contentwise, similar to
the EVs from the cultured cells [12]. Importantly,
FBS EVs are taken up by the cultured cells causing
substantial physiological effects, including altered via-
bility and migration [2]. They are also co-isolated with
cell-culture-derived EVs, causing bias and
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misinterpretation of results. FBS-derived EVs are thus
considered as common contaminants in experiments
aiming to study the EVs released by the cultured cells
or to elucidate the effects of exogenous EVs added to
the medium. Since cell-culture-based EV studies rely
heavily on serum-derived supplements, such as FBS,
development of a cost-effective, standardized, simple
and efficient method for EV depletion of FBS is of
utmost importance.
Currently, there are no standardized protocols for elim-
inating EVs from FBS. Ultracentrifugation (UC) at
100,000–200,000 g for 2–19 h is commonly used for deplet-
ing FBS EVs [7]. However, UC-based EV depletion only
partially depletes EVs from FBS [3,13]. Furthermore, it is a
time-consuming, difficult-to-standardize and relatively
expensive method. Recently, several commercial alterna-
tives have also emerged. However, they are costly and may
also contain residual bovine EVs. Thus, it is necessary to
develop standardized protocols for EV depletion from FBS
in order to minimize the effect of FBS EVs on cell pheno-
type and downstream analysis of EVs. In this study, we
developed a novel protocol based on ultrafiltration (UF) to
deplete EVs from FBS, and addressed the effects of this
ultrafiltration EV-depleted FBS (UF-dFBS) on prolifera-
tion, stress, differentiation and EV production of AT-
MSCs and cancer cell lines in comparison with regular
FBS, ultracentrifugation EV-depleted FBS (UC-dFBS),
commercial EV-depleted FBS (SBI-dFBS) and serum-free
media.
Materials and methods
Preparation of EV-depleted FBS
Ultrafiltration EV-depleted FBS (UF-dFBS) was obtained
by centrifuging regular FBS in Amicon ultra-15 centrifugal
filters (ref: UFC910024, 100kDa Merk Millipore Ltd.,
Tullagreen, Carrigtwohill, Co. Cork, Ireland) for 55 min
at 3,000 g. The liquid concentrated by the ultrafilter was
denoted asUF-dFBS retentate and the flow-through asUF-
dFBS. UC-dFBS was prepared by 19 h ultracentrifugation
of regular FBS at 26 000 rpm (121 896 gmax) using an SW28
rotor (k-factor 284.7, Beckmann-Coulter). Only the light-
coloured top layers of the supernatant (approx. 9/10) were
retained and used in the subsequent analyses. Further, UC-
dFBS was filtered with a 0.22 µm filter (Millipore Stericup-
GP, 0.22 µm, polyethersulfone filter) before addition to
cell-culture medium. Commercially available EV-depleted
FBS (SBI-dFBS), Exo-FBS™ (System Biosciences, EXO-
FBS-50A-1, lot: 082715, Mountain View, CA, USA), was
used as a control. Details of the FBS and dFBS used are
described in Table 1.
Isolation of FBS-derived EVs for characterization
For EV-RNA isolation and a part of electron microscopy
samples, EVs were extracted from regular FBS, different
dFBS or UF-dFBS retentate using the miRCURY exosome
isolation kit (Exiqon, Vedbaek, Denmark) according to the
manufacturer’s instructions. For all other characterization
analyses, EVs were extracted using UC at 26 000 rpm (121
896 gmax) for 2 h at 4°C with SW28 rotor to collect the EV
pellet, whichwaswashed by filtered PBS (0.1 µm filter), and
then the UC was repeated. The final EV pellets were sus-
pended in filtered PBS and stored in Protein LoBindmicro-
centrifuge tubes (Eppendorf) at −80°C.
Nanoparticle tracking analysis (NTA)
The EVs isolated from regular and different dFBS by
UC were analysed by NTA to determine vesicle con-
centration and size distribution using Nanosight model
LM14 (NanoSight Technology, Salisbury, UK, http://
www.malvern.com) equipped with blue (404 nm,
70 mW) laser and CMOS camera (Hamamatsu
Photonics K.K., Hamamatsu City, Japan). The samples
were diluted in filtered (0.1 µm) PBS to obtain the
optimal detection concentration of 106–109 particles/
ml, and three 60 s videos were recorded using camera
level 13. In total, three biological replicates were mea-
sured from each sample. The data were analysed using
NTA software 3.0 with the detection threshold 5 [14].
Table 1. Method for preparing depleted FBS. Prices are without working hour’s costs for hands-on work.
Acronym Full name Method of EV depletion Hands-on time Price excl. VAT Additional requirements
UC-dFBS Ultracentrifugation
EV-depleted FBS
19 h, 26 000 g (SW28 rotor, Beckman-
Coulter)
2 h 32 euros/50 ml Ultracentrifuge,
ultracentrifugation tubes,
electronic scale
UF-dFBS Ultrafiltration EV-
depleted FBS
Amicon ultra-15 centrifugal filters for
55 min at 3000 g (UFC910024, 100K
Merk Millipore Ltd)
10–15 min 48 euros/50 ml Amicon ultra-15 centrifugal
filters and benchtop
centrifuge
SBI-dFBS Exosome-depleted
FBS
System Biosciences, EXO-FBS-50A-1, US
patent method (9,005,888 B2)
None 224 euros/50 ml None
FBS = fetal bovine serum; UC-dFBS = EV-depleted FBS produced by 19 h ultracentrifugation; UF-dFBS = ultrafiltration EV-depleted FBS; SBI-
dFBS = commercial EV-depleted FBS, stripped of bovine CD63 exosomes.
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Transmission electron microscopy (EM)
EV samples isolated by UC or miRCURY exosome
isolation kit from each type of dFBS or regular FBS
were prepared for EM and imaged as described pre-
viously [15]. Briefly, after loading to 200 mesh copper
grids and fixation with 2% PFA in 0.1 M NaPO4 buffer
(pH 7.0), samples were washed with the 0.1 M NaPO4
buffer and deionized water, negatively stained with 2%
neutral uranyl acetate and embedded in methyl cellu-
lose uranyl acetate mixture (1.8/0.4%). Samples from
two or three independent EV isolations, each with two
or more technical replicates, of all sample types were
viewed with transmission EM using Tecnai 12 (FEI
Company, Eindhoven, the Netherlands) or Jeol JEM-
1400 (Jeol Ltd, Tokyo, Japan) operating at 80 kV.
Images were taken with Gatan Orius SC 1000B CCD-
camera (Gatan Inc., USA) with an image size of
4008 × 2672 px and no binning.
Western blotting and silver staining
Western blotting was performed as described previously
[15] using an antibody against Hsp70 (no. 554243, BD
Biosciences) and anti-transferrin receptor/CD71 H68.4
(no. 13–6800, Thermofisher Scientific) at 1:1000 dilution.
EVs isolated by UC from equal volumes (0.5 mL) of each
dFBS were loaded to gels. As controls, 30 µg of protein
from AT-MSC lysates measured by BCA assay (Pierce
BCA Protein Assay Kit) and EVs isolated by UC from
0.25 ml FBS and fromUF-dFBS retentate (corresponding
to approximately 1.5 ml of original FBS) were loaded to
gels. EV samples were denatured at 95°C for 5 min in
reducing Laemmli sample buffer, separated using Mini-
PROTEAN® TGX™ 4–20% gradient SDS-PAGE gel (Bio-
Rad, Hercules, CA, USA) with page ruler prestained
protein ladder (Thermo Scientific, Rockford, IL) as a
standard and blotted on Immobilon-P PVDF membrane
(Millipore, Bedford, MA). Blocking and antibody incuba-
tions were performed in Odyssey blocking buffer (LI-
COR) without or with 0.1% Tween-20, respectively.
Membranes were subsequently probed with IRDye®
800CW Goat anti-Mouse (Li-COR) at 1:15,000 2 hours
at RT. After incubation, membranes were washed three
times in TBS-T for 10minutes at RT and imaged on an
Odyssey FC Imager (Li-COR). For silver staining, EVs
isolated by UC from UF-dFBS retentate (as above) and
equal volumes (0.3 mL) of FBS and the different dFBS
were mixed with loading buffer and heated at 95°C for
5 min. The gel was stained using the Pierce® Silver Stain
Kit (Thermo Scientific) following the manufacturer’s
instructions and imaged by Gel Doc XR imager
(Bio-Rad).
Total RNA extraction and quality control
EVs from equal volumes (5 ml) of regular FBS and
different dFBS, except for the UF-dFBS retentate
(0.5 ml derived from 15 ml of regular FBS) owing to its
consistency, were extracted using the miRCURY exo-
some isolation kit, followed by total RNA extraction
using the miRCURY RNA isolation kit, cell and plant
(Exiqon, Denmark) according to the manufacturer’s
instructions. RNA was also extracted directly from
0.2 ml of the different dFBS and regular FBS or 0.1 ml
of the UF-dFBS retentate (derived from approximately
3 ml of regular FBS) using the miRNEasy Serum/Plasma
kit (Qiagen). Three replicate samples of each type were
analysed with the Bioanalyzer 2100 using the Small RNA
Kit (all Agilent Technologies, Santa Clara, CA, USA).
Isolation and culture of cells
The study was carried out under the approval of the
ethical committee of Helsinki and Uusimaa Hospital
District and with informed consent from the donors.
Ethical approval has been granted for the use of adi-
pose tissue (DNro 217/13/03/02/2015). AT-MSCs were
obtained from water-assisted lipotransfer liposuction
aspirates [16] from four donors using mechanical and
enzymatic isolation as described previously [17]. All
donors were female, with an age range of 33–47 years
and a BMI range of 22.7–25.4. Cells were cultured in
media consisting of Dulbecco’s modified Eagle’s med-
ium/Ham’s Nutrient Mixture F-12 with 1% L-alanyl-L-
glutamine (DMEM/F-12 1:1 GlutaMAX; Gibco ref.
31331–028, lot. 1765,999), 1% antibiotics (100 U/ml
penicillin, 0.1 mg/ml streptomycin; Lonza ref. DE
17–602 E, lot. 5MB 068) and 10% FBS, qualified, EU-
approved, South America origin, Gibco) at 37°C and
5% CO2 [18]. Once AT-MSCs had adhered to the
culture flask, non-adherent populations were washed
away with PBS, and fresh culture media was added.
Isolation and culturing of prostate and renal cancer
patient-tissue-derived cells and mouse 3T3 cells was
carried out as described [19]. The patient-derived cul-
tures were established in regular FBS, after which the
cells were washed three times with PBS before cultur-
ing in the media containing 10% of different dFBS or
in serum-free media for up to 96 h. Details of the used
culture media, i.e. the test media, are described in
Table 2. Osteosarcoma cell line HOS143b (ATCC®
CRL-8303™) and prostate cancer cell line PC-3
(ATCC® CRL-1435™) were purchased from ATCC.
Oral cancer cell line HSC3 was kindly provided by
Prof. Tuula Salo (University of Helsinki).
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Flow cytometry of immunophenotype of adipose-
tissue mesenchymal stem cells
AT-MSCs cultured in FBS media (n = 3) were char-
acterized using BD Accuri C6 flow cytometer (Becton
Dickinson, Franklin Lakes, NJ) to confirm the
mesenchymal origin of the cells. Allophycocyanin
(APC)-conjugated monoclonal antibodies against
CD14 (clone: M5E2), CD19 (clone: HIB19), CD34
(clone: 581), CD45RO (clone: UCHL1), CD54 (clone:
HA58), CD73 (clone: AD2), CD90 (clone: 5E10),
CD105 (clone: 266) and HLA-DR (clone: G46-6) (BD
Pharmingen, Becton Dickinson) were used. Further, to
assess whether AT-MSCs retained their immunophe-
notype after being cultured in media with UC-dFBS or
UF-dFBS compared with FBS for 48 h, AT-MSCs
(n = 3) were analysed for surface markers CD34
(clone: 581), CD45RO (clone: UCHL1), CD54 (clone:
HA58), CD73 (clone: AD2) and CD105 (clone: 266). A
total of 100 000 cells per sample were analysed, and
positive expression was defined as the level of fluores-
cence greater than 99% of the corresponding unstained
cell sample [20].
Proliferation assays
AT-MSCs
Cells (n = 4) were plated at 7500 cells/cm2 in triplicates
per condition in 24-multiwell plates to analyse prolif-
eration in the test media (Table 2). Morphology of the
cells was observed in T25 flasks (7500 cells/cm2) with
4× and 10× magnification using a Nikon Eclipse TS100
inverted phase-contrast microscope (Nikon
Corporation, Tokyo, Japan) equipped with a Nikon
DS-Fi2 camera. Once cell cultures reached 70% con-
fluency, they were washed carefully with PBS and test
media (Table 2) were added. Cells were examined at 48
h and 96 h time points to analyse morphology, meta-
bolic activity (CCK8) and total DNA (CyQuant).
Cancer cells
Cancer cell lines PC3, HSC3 and HOS143b were plated
at 2500 cells/cm2 in triplicates for maintenance in
Dulbecco’s modified Eagle’s medium (DMEM/F-12
1:1 GlutaMAX) supplemented with 10% FBS until
they reached 70% confluency. Then, the cells were
washed with PBS and cultured in the test media
(Table 2). Cells were examined at 48 h and 96 h for
metabolic activity (CCK8) and total DNA (CyQuant).
CCK8
The metabolic activity of live cells was analysed using
the Cell Counting Kit-8 (CCK8) (Dojindo, US). The
principle of the assay is based on the dehydrogenase
activity in viable cells cleaving the tetrazolium salt into
water-soluble coloured formazan dye. The dehydrogen-
ase activity is directly proportional to the number of
living cells. At 48 h and 96 h after adding the test
media (Table 2) to the AT-MSCs, the assay was per-
formed according to the manufacturer’s instructions,
and measured at wavelength 450 nm using a micro-
plate reader (PerkinElmer VICTOR™ X4 Multilabel
Microplate Reader 2030, Turku, Finland).
CyQuant
The total cellular DNA was determined using the
CyQUANT™ Cell Proliferation Assay Kit (CyQUANT;
Molecular Probes, Invitrogen, Paisley, UK) on the same
cells analysed by CCK8. Briefly, at 48 and 96 h time points,
the cells were lysed with 0.1% Triton-X 100 buffer (Sigma-
Aldrich, St. Louis, MO, USA) and analysed after a freeze–
thaw cycle. Fluorescence was measured with a microplate
reader (PerkinElmer VICTOR™ X4 Multilabel Microplate
Reader 2030, Turku, Finland) at 480/520 nm.
ROS-Glo H2O2 assay
Cells from three different AT-MSC donors were plated at
2500 cells/cm2 in triplicates per condition in 96-multiwell
Table 2. Culture media formulation overview.
Acronym Culture media Basal media Manufacturer Serum Supplementation
FBS Normal FBS media DMEM/F12 + Glutamax Gibco, ref. 10270106, lot. 42F8554K 10% FBS 0.1% pen-strep
RPMI 1640 + Glutamaxa
UC-dFBS Ultracentrifugation EV-depleted
FBS media
DMEM/F12 + Glutamax Gibco, ref. 10,270,106, lot. 42F8554K 10% UC-dFBS 0.1% pen-strep
RPMI 1640 + Glutamaxa
UF-dFBS Ultrafiltration EV-depleted FBS
media
DMEM/F12 + Glutamax Gibco, ref. 10,270,106, lot. 42F8554K 10% UF-dFBS 0.1% pen-strep
RPMI 1640 + Glutamaxa
SBI-dFBS Exosome depleted FBS media DMEM/F12 + Glutamax System Biosciences, ref. EXO-FBS-50A-
1 lot. 082715
10% SBI-dFBS 0.1% pen-strep
RPMI 1640 + Glutamaxa
Serum-free Serum-free media DMEM/F12 + Glutamax None 0.1% pen-strep
aRPMI1640 (cat no. BE12-167F) was used for culturing HOS143b.
RPMI = Roswell Park Memorial Institute medium; FBS = fetal bovine serum; UC-dFBS = EV-depleted FBS produced by 19 h ultracentrifugation; UF-
dFBS = ultrafiltration EV-depleted FBS; SBI-dFBS = commercial EV-depleted FBS; DMEM/F12 = Dulbecco’s modified Eagle’s medium/Ham’s Nutrient Mixture
F-12; Pen-strep = penicillin–streptomycin.
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plate to analyse concentration-dependent reactive oxygen
species (ROS) accumulation from cells in FBS, UF-dFBS,
UC-dFBS and serum-free media (Table 2) after 24 and 48
h exposure. Cells were first plated in the FBS medium.
After 24 h, cells were washed carefully with PBS, and then
the test media were added. After 24 h and 48 h, cells were
washed carefully with PBS, and the ROS-GLO H2O2
Assay (Promega Cat. no. G8820/1, lot. no. 0000264704,
Fitchburg, WI, USA) was performed according to the
manufacturer’s instructions. For the luminescence signal
detection, a microplate reader was used (PerkinElmer
VICTOR™ X4 Multilabel Microplate Reader 2030,
Turku, Finland).
Osteogenic differentiation
Cells from three different donors were plated at 2500
cells/cm2 in duplicates per condition in a 24-multiwell
plate to analyse whether the AT-MSCs could retain
their osteogenic potential after 48 h exposure to FBS
and dFBS media. Cells were first plated in the FBS
medium. After 24 h, cells were washed carefully with
PBS, and then the test media were added. After 48 h,
cells were washed carefully with PBS, and osteogenic
differentiation was induced using osteogenic medium
(FBS medium supplemented with 50 µM L-ascorbic
acid 2-phosphate, 10 mM β-glycerophosphate diso-
dium salt hydrate and 5 nM dexamethasone (all
Sigma-Aldrich)). After 7 days of osteogenic differentia-
tion, cells were lysed, and RNA extraction was per-
formed using the Nucleospin RNA kit (Macherey-
Nagel, Ref. no. 740955.50, Düren, Germany) according
to the manufacturer’s instructions. The concentration
and purity of RNA was measured using NanoDrop-
1000 (Thermo Fisher Scientific, Waltham, MA, USA).
Quantitative reverse transcription PCR (qRT-PCR)
Gene expression was analysed from AT-MSCs from three
donors. Total RNA was converted into cDNA by reverse
transcription using a SuperScript™ IV VILO™ reaction
mixture (Thermo Fisher Scientific). Gene expression was
quantified using TaqManR ©assays (Thermo Fisher
Scientific). RUNX2 (Hs01047973_m1) expression was
measured as an early indicator of osteogenesis, and three
housekeeping genes, TBP (Hs00427620_m1), RPLP0
(Hs99999902_m1) and YWHAZ (Hs03044281_g1), were
used to normalize the data [21]. The PCR reactions were
conducted in triplicates using the Applied BiosystemsR©
7500 Fast Real-Time PCR System (Thermo Fisher
Scientific). Data were analysed using the 2ΔΔCt method
to quantify the relative gene expression [22].
Cell adhesion assays
Fibronectin supplementation
AT-MSCs were plated at 7500 cells/cm2 in triplicates
on a normal 24-well plate in the FBS medium. After 24
h, cells were washed carefully with PBS, and then the
test media were added (Table 2). UF-dFBS media were
supplemented with 20 µg/ml Native Fibronectin
Human Protein (Gibco/Thermofisher Scientific, cat
no. PHE0023). After 48 h and 96 h, cells were washed
carefully with PBS, and CCK8 and CyQuant analyses
were performed.
Carboxyl-coated plates
Carboxyl plates are enhanced attachment surfaces pro-
duced through vacuum-gas plasma carboxyl group poly-
merization treatment. They are chemically defined and
free of any animal-derived substances supporting attach-
ment and proliferation of cells. AT-MSCs were plated at
2500 cells/cm2 in triplicates on carboxyl coated 24-multi-
well plates (Corning™ PureCoat™ Carboxyl Cat. no.
356773, Lot. no. 6,237001, New York, NY, USA) and on
regular tissue culture treated 24-multiwell plates to ana-
lyse cell proliferation. Cells were plated in the FBS med-
ium to allow uniform and equal attachment of cells. After
24 h, cells were washed carefully with PBS, and then the
media supplemented with UF- or UC-dFBS (Table 2)
were applied. Cells cultured in both plate types were
analysed for metabolic activity (CCK8) at 48 h.
Assessment of EV production by AT-MSCs and
cancer cell lines
NTA analysis was performed on EVs isolated from AT-
MSCs (n = 2) and PC-3 cells (n = 1) cultured in the test
media (Table 2). Briefly, cells were plated at 7500 cells/
cm2 in triplicates on a normal 24-well plate in FBS med-
ium. After 24 h, cells were washed carefully with PBS, and
then the test media were added. After 48 h, the media
were collected and centrifuged at 2500 g for 20 min at +4°
C, followed by EV extraction by UC (121 896 gmax, for 1.5
h). EV pellets were resuspended in 200 µl of PBS and
analysed with NTA as described. Particle numbers of
similar UC preparations from all of the fresh test media
were subtracted from particle numbers derived from the
harvested media at the 48 h time point to assess the
number of particles produced by the cells.
Statistical analysis
As biological replicates, three or four donor cell sam-
ples of AT-MSCs and three different cancer cell lines
were analysed using three technical replicates of each
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in all assays. The graphs (Figures 1, 6, 7, 8 and
Supplemental Figure 2) show the biological and/or
technical replicates with means. Statistical analyses
were performed using GraphPad Prism 6 (GraphPad
Software Inc., CA) statistical software. For CCK8/
CyQuant assays, ROS-Glo assays and flow cytometry,
statistical analyses were performed using ANOVA two-
way analysis of variance. Bonferroni post-hoc tests
were used to determine individual significant differ-
ences. The results were considered significant when
the Bonferroni corrected p-value was below 0.05.
Results
Analysis of the different EV-depleted FBS
absence of EVs in our UF-dFBS and other dFBS prepara-
tions/absence of EVs in our UF-dFBS and other dFBS
preparations, we isolated EVs remaining in the dFBS by
ultracentrifugation or using the miRCURY exosome iso-
lation kit and characterized them using NTA, EM,
Western blotting and RNA analyses. The NTA results
showed that the UF-dFBS had similar low amounts of
particles to that of SBI-dFBS, whereas only partial deple-
tion of EVs was observed in UC-dFBS (Figure 1).
Characterization of the EV samples by EM mostly sup-
ported the NTA results (Figure 2). While the UF-dFBS
samples were essentially EV-free, UC-dFBS and SBI-
dFBS still contained some EVs or other EV-like particles
that were mainly small (<200 nm). As expected, regular
FBS contained both large and small EVs. The results were
similar when EV isolation was carried out using either
UC (Figure 2) or the commercial kit (Supplementary
Figure 1).
Next, we performed a total protein analysis by silver
staining. When analysing EVs, UF-dFBS was the only
dFBS that showed an almost complete removal of EV
proteins (Figure 3(a)). Indeed, EV preparations of all
other dFBS, FBS and the UF-dFBS retentate had a similar
kind of pattern of protein bands. Furthermore, in
Western blotting, the EV marker Hsp70 was absent, and
only a faint band of CD71 protein was detected in the UF-
dFBS sample (Figure 3(b)). Both EV markers gave faint
bands from the UC-dFBS sample, whereas the corre-
sponding bands were clearer in the SBI-dFBS and UF-
dFBS retentate samples. The strongest bands for Hsp70
and CD71 were detected in the regular FBS sample.
We further verified the EV depletion efficiency of the
UF protocol by RNA extraction from EVs isolated from
all dFBS preparations. RNA analysis with the Bioanalyzer
Small RNA kit showed no EV-RNA peaks from UF-dFBS
samples, whereas small amounts of EV-RNA were
obtained from SBI-dFBS and UC-dFBS (Figure 4(a)).
EVs from regular FBS contained the largest amount of
small RNA. EVs from the UF-dFBS retentate served as a
control and contained EV-RNA as well.
Since the FBS contains both intra- and extra-vesicu-
lar RNA, we also investigated the amount of total RNA
present in the different dFBS and regular FBS (without
prior EV isolation) (Figure 4(b)). Bioanalyzer results
indicated that all the FBSs, including UF-dFBS, con-
tained some RNA. The amount of total RNA was low-
est in the UF-dFBS followed by SBI-dFBS, UC-dFBS
and FBS. UF-dFBS retentate, included as a control, also
contained RNA. The results therefore suggest that the
filtration protocol removed all the EV-RNA, but still
retained some soluble RNA in the UF-dFBS. Together,
these results indicate that UF was the only method to
completely deplete EVs from the FBS.
Effect of EV-depleted FBS on cell proliferation
In order to analyse the effects of the different dFBS-
supplemented media on cell adhesion and prolifera-
tion, the media were tested on AT-MSCs and com-
pared with regular FBS medium (Table 2). The AT-
MSC proliferation tests (Figure 6(a)) were performed
on cell lines from four donors, with assays run twice on
two cell lines in order to reduce donor variability.
According to the standards defined by the
International Society for Cellular Therapy (ISCT),
MSCs should be adherent to plastic under normal
culturing conditions, have fibroblast-like morphology
and show a specific immunophenotype measured by
flow cytometry [23,24]. In concordance with these
guidelines, AT-MSC donor cell lines grown in the
FBS-supplemented medium expressed surface markers
CD73, CD90 and CD105, and lacked the expression of
CD14, CD19, CD45 and HLA-DR (Table 3). In addi-
tion, CD34 was only moderately expressed, as pre-
viously reported for AT-MSCs cultured in FBS media
[25]. CD54 expression also conformed to the previous
reports of AT-MSCs in FBS media [25]. Further, when
we assessed the surface marker expression in AT-MSCs
after their culture in the different dFBS media vs. the
FBS medium, we detected no statistically significant
differences. Yet, a trend towards a higher expression
of CD34 and CD54 in UF-dFBS was seen (Table 3). We
also observed the cell morphology via light microscopy
after culturing in all the test media (Table 2) for 48 h
and 96 h (Figure 5). In all conditions, we detected a
characteristic mesenchymal stem cell morphology, i.e. a
small spindle-shaped cell body with a few long and thin
cell processes, during the 96 h follow-up period.
Proliferation was measured in AT-MSCs grown in
all the test media (Table 2, Figure 6(a) and
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Supplemental Figure 2). Metabolic activity normalized
to total DNA, i.e. cell proliferation, in FBS and UC-
dFBS media was comparable at both time points of 48
h and 96 h with significant donor variability, particu-
larly at 96 h. At the 48 h time point, proliferation of the
cells grown in UF-dFBS was similar to proliferation of
cells grown in FBS, UC-dFBS or SBI-dFBS. However, at
96 h, the cells grown in the UF-dFBS and SBI-dFBS
proliferated more slowly than the cells grown in media
supplemented with other sera, although these
Figure 1. EV concentration and size distribution by nanoparticle tracking analysis (NTA). Concentrations (particles/ml of original FBS)
are shown in the y-axis and the different EV-depleted FBS and regular FBS samples on the x-axis. The UF-dFBS and commercial EV-
depleted FBS (SBI-dFBS) contained fewer particles than the UC-dFBS or regular FBS. The dots depict measurements from technical
replicates, and bars show means. FBS (fetal bovine serum), UC (ultracentrifugation), UF (ultrafiltration), SBI (System Biosciences),
dFBS (EV-depleted FBS).
Figure 2. Electron microscopy of EV-depleted and regular FBS. Electron microscopy revealed that EVs were absent only in the UF-
dFBS. EVs were isolated by UC from the different EV-depleted FBS and regular FBS. EV preparations were derived from (a) UF-dFBS
lacked EVs, whereas (b) UC-dFBS and (c) commercial dFBS (SBI-dFBS) preparations showed mainly small EVs or EV-like particles. (d)
Regular FBS contained both small and large EVs. Arrowheads mark examples of the EVs detected in the samples. The scale bar
(500 nm) applies to all images. FBS (fetal bovine serum), UC (ultracentrifugation), UF (ultrafiltration), SBI (System Biosciences), dFBS
(EV-depleted FBS).
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differences were not statistically significant (Figure 6
(a)). Cell proliferation was the lowest in the serum-free
medium at each time point. In summary, all media
except for serum-free media were able to maintain
AT-MSC proliferation until 96 h.
We also assessed cell proliferation of three differ-
ent cancer cell lines (HSC3, PC-3, HOS143b) in the
test media at 48 h and 96 h (Figure 6(b)). Here, we
observed a stimulating effect on cell proliferation in
all three cancer cell lines when they were cultured in
the UF-dFBS media in comparison with the other
test media. Metabolic activity and total DNA count
for each cell type are shown in the Supplement
Figure 2. In addition, we tested UF-dFBS for cultur-
ing of mouse 3T3 cells and conditionally repro-
grammed cells [26] derived from prostate (as
described in [19]) and renal cancer [Saeed et al.,
unpublished results] patient tissue samples. All cell
types cultured for up to 72h (n = 12) exhibited no
apparent arrest in the proliferation (data not shown).
In all, the cell proliferation assays showed that UF-
dFBS medium supported cell proliferation, indicating
that it can be used for a range of cell types including
AT-MSCs.
Evaluation of ROS levels and stem cell
differentiation of AT-MSCs grown in dFBS
It is known that the stress levels of cells correspond to
the levels of ROS released. Therefore, we analysed the
ROS levels after 24 h and 48 h of cell culture in UF-
dFBS, UC-dFBS, FBS or serum-free media. The AT-
MSCs grown in the serum-free media released
significantly more ROS than the cells grown in all the
other media already at 24 h (p < 0.05, Figure 7). There
was no statistically significant difference in the ROS
levels after 24 h among the UF-dFBS, UC-dFBS or
regular FBS conditions. After 48 h, there was a signifi-
cant difference in the ROS accumulation between the
serum-free and regular FBS media, as well as between
the serum-free and UC-dFBS media (both p < 0.05,
Figure 7).
Next, after being cultured for 48 h in the dFBS
media and serum-free conditions, AT-MSCs were
induced for 7 days in the osteogenic differentiation
media (containing regular FBS) to evaluate whether
the AT-MSCs retained their capacity to differentiate
into osteoclasts. RT-PCR analysis of early osteogenic
marker RUNX2 showed that the osteogenic differentia-
tion capacity of AT-MSCs was not affected by the UF-
dFBS, UC-dFBS or serum-free media (Figure 8(a)). In
summary, none of the dFBS media induced elevated
ROS levels or altered the differentiation capacity of the
AT-MSCs.
Improvement of cell proliferation in the dFBS
media with carboxyl plates
To test if the cell proliferation rate of AT-MSCs
grown in the UF-dFBS media could be increased,
we compared different means of improving cell
adhesion: supplementation of an extracellular matrix
protein, fibronectin and carboxyl plates. First, we
tested fibronectin supplementation into medium in
combination with UF-dFBS. Proliferation in this
medium was compared with the proliferation in the
Figure 3. Silver staining and Western blotting of EV proteins. Analysis of total EV-protein and EV-marker proteins Hsp70 and CD71.
EVs were isolated by UC from the different EV-depleted FBS and regular FBS. (a) Silver staining of EV proteins derived from regular
FBS shows a distinct protein pattern that can also be detected in UC-dFBS, commercial dFBS (SBI-dFBS) and UF-dFBS retentate, but
not in the UF-dFBS. (b) Western blotting detected Hsp70 and CD71 in EV preparations derived from regular FBS, UC-dFBS, SBI-dFBS
and UF-dFBS retentate. In contrast, only a faint band of CD71 and no Hsp70 could be detected in EV preparations from UF-dFBS. FBS
(fetal bovine serum), UC (ultracentrifugation), UF (ultrafiltration), SBI (System Biosciences), dFBS (EV-depleted FBS).
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other dFBS and regular FBS media. However, we
repeated this study with only one donor cell line, as
we detected no improvement in cell proliferation
(data not shown). Next, we cultured AT-MSCs for
48 h in UF-dFBS or UC-dFBS media on carboxyl
plates compared with normal cell-culture plates.
Cells proliferated significantly faster on the carboxyl
plates than on regular plates (Figure 8(b)). We
observed a similar trend for cells grown in both
UF- and UC-dFBS media, but the increase in prolif-
eration rate was the highest in cells grown in the UF-
dFBS medium.
Figure 4. Bioanalyzer profiles of small RNA (miRNA and small RNA, 6–150 nt) from different EV-depleted FBS. (a) RNA was extracted
from the EVs isolated from the FBS, dFBS and UF-dFBS retentate. (b) RNA was extracted from the total FBS and dFBS (without prior
EV isolation) or from UF-dFBS retentate. As compared with the other dFBS, the UF-dFBS showed no EV-RNA signal, whereas some
RNA was detected from the total UF-dFBS, indicating its non-vesicular origin. All other samples contained EV- and total FBS-RNA.
FBS (fetal bovine serum), UC (ultracentrifugation), UF (ultrafiltration), SBI (System Biosciences), dFBS (EV-depleted FBS).
Table 3. Surface marker expression (%) of undifferentiated AT-MSCs analysed by flow cytometric analysis.
Antigen Surface protein FBS UC-dFBS UF-dFBS
CD14 Serum lipopolysaccharide-binding protein 0.3 ± 0.1
CD19 B lymphocyte-lineage differentiation antigen 0.1 ± 0.1
CD34 Sialomucin-like adhesion molecule 33.2 ± 11 21.9 ± 14 47.3 ± 17.7
CD45 Leukocyte common antigen 0.3 ± 0.1 0.4 ± 0.2 0.5 ± 0.3
CD54 Inter-cellular adhesion molecule 43 ± 17.1 43.1 ± 14.3 69.1 ± 15.6
CD73 Ecto-5′-nucleotidase 100 ± 0 100 ± 0 99.8 ± 0.2
CD90 Thy-1 (T-cell surface glycoprotein) 100 ± 0.1
CD105 SH-2, endoglin 98.4 ± 0.9
HLA-DR Major histocompatibility class II antigens 0.1 ± 0.1
AT-MSCs = adipose-tissue-derived mesenchymal stem cells; FBS = fetal bovine serum; UC-dFBS = EV-depleted FBS produced by 19 h ultracentrifugation; UF-
dFBS = ultrafiltration EV-depleted FBS.
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NTA analysis of EV production in dFBS
Finally, we studied whether EV production of AT-
MSCs and PC-3 cells was affected by the UF-dFBS
and UC-dFBS media in comparison with the regular
FBS medium. AT-MSCs (Figure 8(c)) and PC-3 cells
(Figure 8(d)) cultured in all the media produced equal
numbers of particles as measured by NTA. Thus, the
EV production by the cultured cells was not affected by
either dFBS.
Discussion
As FBS is the most commonly used supplement in cell
cultures, the removal of EVs from FBS is of high
importance for in vitro EV studies. FBS EVs have
been reported to be internalized by the recipient cells
and to affect them physiologically, for example by
inducing cell migration [2,3]. Therefore, studies focus-
ing on the functions of EVs released by the cultured
Figure 5. Morphological characterization of adipose-tissue derived mesenchymal stem cells by light microscopy after culturing in
the test media for 48 h and 96 h. No differences could be detected in the size or shape between the different culturing conditions
when monitored for up to 96 h. The spindle-shaped body of cells could be observed in all images and time points. Scale bars are
100 µm. FBS (fetal bovine serum), UC (ultracentrifugation), UF (ultrafiltration), SBI (System Biosciences), dFBS (EV-depleted FBS).
a b
Figure 6. Cell proliferation and metabolic activity of AT-MSCs and cancer cell lines in test media. Metabolic activity per cell, i.e. cell
proliferation, was calculated by the ratio of CCK8/CyQuant. (a) Adipose-tissue mesenchymal stem cells (AT-MSCs) showed a similar
proliferation rate in FBS and UC-dFBS media between 48 h and 96 h, which was somewhat higher than in UF-dFBS and SBI-dFBS
media. No marked proliferation was detected in the serum-free conditions. Each dot represents a biological replicate, and bars show
means. (b) Proliferation rate of three different cancer cell lines (HSC3, PC-3, HOS143b) in FBS and dFBS media were assessed at 48 h
and 96 h. UF-dFBS had a stimulatory effect on the proliferation of all three cancer cell lines. Each dot represents a technical
replicate, and bars represent means. FBS (fetal bovine serum), UC (ultracentrifugation), UF (ultrafiltration), SBI (System Biosciences),
dFBS (EV-depleted FBS).
Figure 7. Evaluation of H2O2 formation in AT-MSCs grown in
FBS, UC-dFBS, UF-dFBS and serum-free culture conditions after
24 h and 48 h. After 48 h, a significant difference was seen
between the serum-free and regular FBS media (*p < 0.05), as
well as between the serum-free and UC-dFBS media
(*p < 0.05). Dots represent biological and technical replicates,
and bars represent means. AT-MSCs (adipose-tissue mesenchy-
mal stem cells), FBS (fetal bovine serum), UC (ultracentrifuga-
tion), UF (ultrafiltration), dFBS (EV-depleted FBS).
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cells, or of supplemented EVs from another cell type,
become compromised if FBS-derived EVs are also pre-
sent. Furthermore, contamination of the media with
FBS EVs [12,13] may confound potential markers in
studies aiming to identify EV-derived biomarkers from
cultured cells.
Recently, an RNA sequencing analysis by Wei and
co-workers revealed that FBS contains protein-coding
and regulatory RNAs including miRNA, rRNA,
snoRNA and Y-RNA, which are indistinguishable
from human and mouse transcripts, suggesting that
FBS-derived RNA could potentially influence extracel-
lular RNA analysis from both human and mice [13].
FBS-derived RNA has also been detected in publicly
available extracellular RNA sequencing datasets from
several cell cultures, indicating that bovine RNA is a
common contaminant among extracellular RNA [27].
Notably, mir-122, mir-451a and mir1246 previously
reported to be abundant in cell-culture-derived EVs
have now been shown to actually originate from the
FBS EVs [13]. Overall, previous studies clearly suggest
that the removal of FBS EV-derived RNA is of high
priority, as it competes with or confounds the EV-RNA
in focus [13,27].
Despite the obvious need, there are currently no
standardized protocols for eliminating EVs from
FBS. UC is commonly used for obtaining EV-
depleted FBS. However, UC even up to 24 h only
partially removes the EVs or EV-RNA [3,13,27], and
the protocols are very heterogeneous [28]. Removal
of FBS EVs is sensitive to multiple equipment, pro-
tocol or handler-dependent parameters (steps before
pelleting, viscosity/dilution/volume of FBS, centrifu-
gation time and speed, used supernatant fraction as
well as the tube and rotor type determining for
example angle of sedimentation, maximum radius,
usable g-force and pelleting efficiency), and unfortu-
nately, the details about the parameters are often not
provided in publications. Inevitably, this produces
variability in the results from different laboratories.
Commercial alternatives of EV-depeleted sera are
produced using other methods and may still suffer
from incomplete removal of FBS EVs. Thus, lack of
details and harmonization of the dFBS production
a b
c d
Figure 8. Differentiation capacity and improvement of metabolic activity of AT-MSCs cultured in EV-depleted FBS media. (a) Real-
time quantitative PCR analysis of RUNX2 expression of AT-MSCs cultured in dFBS media followed by osteogenic differentiation
showed that the cells retained their osteogenic differentiation capacity. Dots represent biological replicates, and bars represent
means. (b) Compared with normal cell-culture plates, carboxyl plates enhanced the metabolic activity, CCK8 of cells cultured in UF-
dFBS (*p < 0.05) and in UC-dFBS up to 48 h. Dots represent biological and technical replicates and bars represent mean. (c)
Nanoparticle tracking analysis showed an equal production of EVs by AT-MSCs and (d) PC-3 cells cultured in the FBS and dFBS
media. Dots represent biological and technical replicates, and bars represent the means. AT-MSCs (adipose-tissue mesenchymal
stem cells), FBS (fetal bovine serum), UC (ultracentrifugation), UF (ultrafiltration), dFBS (EV-depleted FBS).
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renders comparison of the EV research results from
different laboratories very difficult.
Our UF-based method for EV depletion from FBS
appears to be an effective alternative for the existing
methods. First, it can be standardized and performed
in any laboratory using common, non-expensive
equipment. Second, according to our NTA, EM, pro-
tein and RNA results, the UF-dFBS did not contain
any detectable EVs. As no EV-RNA signal was
detected from the UF-dFBS, and it still supported
EV production from the cultured cells, its use offers
the possibility of obtaining only pure cellular EVs
and their RNA for downstream analyses. Third, com-
pared with cell cultures grown in serum-free media,
cells grown in the media supplemented with UF-
dFBS had a higher viability and proliferation rate
and lower stress levels. Thus, the UF-based method
yields truly EV-free serum, which is crucial for cell-
culture-based EV research.
The measurement of total EV-protein from all the
EV-depleted FBS showed that our UF-dFBS contained
very small amounts of EV proteins. The UF filter used
in this study retains proteins larger than 100 kDa,
allowing smaller proteins to pass into the filtrate. This
is likely to enable cell growth and potentially extracel-
lular matrix production (ECM) by the cells [29,30].
However, it has been reported that the lack of large
molecules, such as glycoproteins, may have adverse
effects on cell differentiation and proliferation [31]. In
addition, the stimulating effect of FBS-derived EVs on
cell proliferation and differentiation has been shown to
affect the biological outcome of the cells [3]. Although
not observed in our cancer cell cultures, the lack of
large proteins and EVs could potentially be the cause of
the slower cell proliferation of AT-MSCs in the UF-
dFBS-supplemented media compared with FBS supple-
mented media during longer cultures (up to 96 h) on
normal cell culture plates. Similarly to the UF-dFBS,
UC-dFBS has also been reported to induce decreased
growth rate, migration rate and differentiation capacity
in some cell types, such as lung epithelial cells (A549)
[3], cardiac progenitor cells [32], human U87 glioblas-
toma cells, human HEK293t cells, human SH-SY5Y
neuroblastoma cells and mouse N2a neuroblastoma
cells [2]. However, with UF-dFBS media, the prolifera-
tion rate still increased between 48 and 96 h, which is a
sign of adjustment to the low-nutrient conditions, i.e.
the cells in UF-dFBS were viable and proliferating.
Importantly, although the cell proliferation was lower
in UF-dFBS media than in UC-dFBS and regular FBS, a
large heterogeneity in the proliferation rates in UC-
dFBS and FBS media was detected compared with in
UF-dFBS media. Since there was less variation between
the test repeats in UF-dFBS supplemented medium
than other media, UF-dFBS appears to offer enhanced
reproducibility.
The flow cytometry data pointed towards a tendency
for a higher expression of CD34 [33] and CD54 expres-
sion in AT-MSCs cultured in UF-dFBS on normal cell-
culture plates. Both of these markers relate to cell adhe-
sion, suggesting that UF-dFBS medium may support less
cell adhesion than FBS and UC-dFBS media. This is
potentially due to the lack of large molecules such as
glycoproteins in the UF-dFBS media causing adaptation
of the cells via upregulation of adhesion molecule expres-
sion. First, as an attempt to rescue cell attachment, and
second, to enhance proliferation, we employed fibronec-
tin and enhanced attachment plates (carboxyl plates).
Although no effect was obtained by fibronectin-supple-
mented medium, carboxyl plates successfully improved
the proliferation rates. Thus, by optimization of cell
attachment, the UF-FBS may also support higher prolif-
eration rates. Further, since EV production or differen-
tiation capacity of cells was not compromised by the UF-
dFBS media even on normal cell-culture plates, our
results support wide applicability of the UF protocol for
EV research.
The clinical use of MSC EVs requires a scale-up of
the EV production, good manufacturing practice
(GMP) protocols and numerous other regulatory con-
siderations [34]. One of the safety considerations is the
use of animal free/bovine EV-free media. In that
regard, our UF depletion protocol producing EV-free
serum, which still supports EV production, could be
applied to any sera including human serum, thus pro-
viding a good option for the future GMP production of
EVs for clinical applications in regenerative medicine
and therapy [10].
In conclusion, we have shown for the first time that
completely EV-free dFBS can be easily prepared in any
research laboratory. Our UF-dFBS method is cost-
effective and simple to standardize, and supports cell
proliferation for up to 96 h, which covers the duration
of most published EV experiments. Utilization of the
UF-dFBS protocol by the EV research community will
help the researchers to obtain pure cellular EVs with
high confidence, thus improving the quality of their
research. Thus, UF-dFBS offers an attractive alternative
for serum-free conditions or UC-dFBS for future EV
research including clinical applications.
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